Related Experiment Video
Updated: Jun 26, 2025

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
The natural polyphenol fisetin in atherosclerosis prevention: a mechanistic review
Wei Yu1,2,3, Yaping Zhao4, Iqra Ilyas4
1School of Materials Science and Engineering, Hefei University of Technology, Hefei, Anhui, 230009, China.
Abstract:
The incidence and mortality rate of atherosclerotic cardiovascular disease (ASCVD) is increasing yearly worldwide. Recently, a growing body of evidence has unveiled the anti-atherosclerotic properties of fisetin, a natural polyphenol compound. In this article, we reviewed the pharmacologic actions of fisetin on experimental atherosclerosis and its protective effects on disease-relevant cell types such as endothelial cells, macrophages, vascular smooth muscle cells, and platelets. Based on its profound cardiovascular actions, fisetin holds potential for clinical translation and could be developed as a potential therapeutic option for atherosclerosis and its related complications. Large-scale randomized clinical trials are warranted to ascertain the safety and efficacy of fisetin in patients with or high risk for ASCVD.
Insights
Fisetin, a natural polyphenol, shows promise in combating atherosclerotic cardiovascular disease (ASCVD). Research indicates its protective effects on blood vessels and cells, suggesting potential as a future therapy for atherosclerosis.
Area of Science:
- Cardiovascular Research
- Pharmacology
- Natural Product Chemistry
Background:
- Atherosclerotic cardiovascular disease (ASCVD) incidence and mortality are rising globally.
- Fisetin, a natural polyphenol, has emerged as a compound with potential anti-atherosclerotic properties.
Purpose of the Study:
- To review the pharmacologic actions of fisetin in experimental atherosclerosis.
- To evaluate fisetin's protective effects on key cardiovascular cell types.
Main Methods:
- Literature review of studies on fisetin and experimental atherosclerosis.
- Analysis of fisetin's effects on endothelial cells, macrophages, vascular smooth muscle cells, and platelets.
Main Results:
- Fisetin demonstrates significant anti-atherosclerotic effects in experimental models.
- Fisetin exhibits protective actions on various cardiovascular cell types relevant to atherosclerosis.
Conclusions:
- Fisetin possesses profound cardiovascular actions with potential for clinical translation.
- Further large-scale randomized clinical trials are needed to confirm fisetin's safety and efficacy in ASCVD patients.
More Related Videos
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
12:00Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Cancer Prevention
Some...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...